Which one of the following drugs has been shown to offer protection from gastric aspiration syndrome in a patient with symptoms of efflux –
**Question:** Which one of the following drugs has been shown to offer protection from gastric aspiration syndrome in a patient with symptoms of efflux -
A. Ranitidine
B. Metoclopramide
C. Ondansetron
D. Domperidone
**Correct Answer:** **C. Ondansetron**
**Core Concept:**
Gastric aspiration syndrome is a condition characterized by the regurgitation of gastric contents into the respiratory tract, leading to potential aspiration pneumonia and complications. In patients experiencing efflux symptoms, medications aimed at reducing gastric acidity, increasing motility or both, may help prevent aspiration.
**Why the Correct Answer is Right:**
Ondansetron is a selective serotonin receptor antagonist, specifically targeting serotonin receptor subtype 5-HT3. By blocking this receptor, Ondansetron reduces the excitability of the lower oesophageal sphincter and gastric emptying, leading to decreased gastric acidity and gastric emptying. This combination results in better protection against gastric aspiration.
**Why Each Wrong Option is Incorrect:**
A. Ranitidine (H2-receptor antagonist) and C. Ondansetron (5-HT3 receptor antagonist) both reduce gastric acidity, but Ondansetron offers additional protection via gastric emptying modulation, making it more effective.
B. Metoclopramide (Dopamine receptor agonist) primarily stimulates the dopamine D2 receptors, which can increase gastric acidity and motility. This makes Metoclopramide less suitable for preventing gastric aspiration.
D. Domperidone (Dopamine receptor agonist) primarily stimulates dopamine D2 receptors, which can increase gastric acidity and motility. While Domperidone may be useful in other contexts, its efficacy in preventing gastric aspiration is inferior to that of Ondansetron.
**Clinical Pearl:**
The combination of reducing gastric acidity and emptying can significantly decrease the risk of aspiration in patients with efflux symptoms. In this context, Ondansetron is the preferred choice over Ranitidine due to its additional impact on gastric emptying. This is especially relevant in patients with conditions like gastroesophageal reflux disease (GERD), where the risk of gastric aspiration is higher due to increased gastric acidity and impaired gastric emptying.